29/09/2010Lundbeck picks Alliance Healthcare as sole UK distributor
Global pharmaceutical giant Lundbeck has appointed Alliance Healthcare as the sole distributor of its products in the UK.
In a statement, Lundbeck, which specialises in pharmaceuticals for the treatment of disorders including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington's disease, epilepsy and insomnia, said it chose Alliance Healthcare to improve supply chain efficiency.
Lundbeck said that Alliance Healthcare was a distributor with a tried and tested infrastructure and extensive knowledge of pharmaceutical wholesale. Under the deal, pharmacies will get twice daily deliveries of Lundbeck products.
Lundbeck managing director Stephen Turley said: “Over the past year there have been challenges in ensuring effective supply to UK patients. We have spoken with a number of stakeholders, including government, pharmacists and prescribers in order to understand how we might address this. We are confident these new distribution arrangements will go a long way towards achieving this.”
Alliance Healthcare commercial healthcare director Mark Stephenson said: “We are delighted to be working with Lundbeck as their distribution partner for this range of specialist medicines. Customers should be assured that we are committed to maintaining the highest levels of service on Lundbeck products and we will be communicating full details of this latest supply chain change in preparation for go-live on 1 November 2010.”
In Northern Ireland, Alliance Healthcare has sub-contracted the delivery of Lundbeck products to Sangers (NI). Alliance Healthcare and Sangers will also be communicating directly with customers in this region to confirm specific ordering processes via Sangers.
Wednesday, September 29, 2010
Lundbeck picks Alliance Healthcare as sole UK distributor - Chemist + Druggist
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment